GB0516496D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB0516496D0
GB0516496D0 GB0516496A GB0516496A GB0516496D0 GB 0516496 D0 GB0516496 D0 GB 0516496D0 GB 0516496 A GB0516496 A GB 0516496A GB 0516496 A GB0516496 A GB 0516496A GB 0516496 D0 GB0516496 D0 GB 0516496D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0516496A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GB0516496A priority Critical patent/GB0516496D0/en
Publication of GB0516496D0 publication Critical patent/GB0516496D0/en
Priority to CA2611376A priority patent/CA2611376C/en
Priority to US11/922,074 priority patent/US8163956B2/en
Priority to ES06744198.0T priority patent/ES2536351T3/en
Priority to EP06744198.0A priority patent/EP1899294B1/en
Priority to JP2008516399A priority patent/JP5340729B2/en
Priority to PCT/GB2006/002156 priority patent/WO2006134341A1/en
Priority to AU2006258842A priority patent/AU2006258842B2/en
Ceased legal-status Critical Current

Links

GB0516496A 2005-06-13 2005-08-11 Therapeutic agents Ceased GB0516496D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB0516496A GB0516496D0 (en) 2005-08-11 2005-08-11 Therapeutic agents
CA2611376A CA2611376C (en) 2005-06-13 2006-06-13 Therapeutic agents
US11/922,074 US8163956B2 (en) 2005-06-13 2006-06-13 Inhibitors of GLYT1 transporters
ES06744198.0T ES2536351T3 (en) 2005-06-13 2006-06-13 Therapeutic agents
EP06744198.0A EP1899294B1 (en) 2005-06-13 2006-06-13 Therapeutic agents
JP2008516399A JP5340729B2 (en) 2005-06-13 2006-06-13 Therapeutic agent
PCT/GB2006/002156 WO2006134341A1 (en) 2005-06-13 2006-06-13 Therapeutic agents
AU2006258842A AU2006258842B2 (en) 2005-06-13 2006-06-13 Therapeutic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0516496A GB0516496D0 (en) 2005-08-11 2005-08-11 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB0516496D0 true GB0516496D0 (en) 2005-09-14

Family

ID=34984443

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0516496A Ceased GB0516496D0 (en) 2005-06-13 2005-08-11 Therapeutic agents

Country Status (1)

Country Link
GB (1) GB0516496D0 (en)

Similar Documents

Publication Publication Date Title
EP1962961A4 (en) Demibodies: dimerisation-activated therapeutic agents
GB0506147D0 (en) Therapeutic agents
EP1730148A4 (en) Aminobenzoxazoles as therapeutic agents
GB0519797D0 (en) Therapeutic agents
GB0521139D0 (en) Therapeutic agent
GB0505437D0 (en) Therapeutic agents
GB0505725D0 (en) Therapeutic agents
GB0516091D0 (en) Therapeutic agent
GB0519350D0 (en) Therapeutic agents
GB0518819D0 (en) Therapeutic agents
GB0518817D0 (en) Therapeutic agents
GB0403780D0 (en) Therapeutic agents
GB0516661D0 (en) Therapeutic agents
GB0514738D0 (en) Therapeutic agents
GB0507003D0 (en) Therapeutic
GB0518720D0 (en) Therapeutic combination
GB0501655D0 (en) Therapeutic use
GB0523998D0 (en) Therapeutic agents
GB0508153D0 (en) Therapeutic agent
GB0400193D0 (en) Therapeutic agents
GB0522433D0 (en) Therapeutic agents
GB0400196D0 (en) Therapeutic agents
GB0402918D0 (en) Therapeutic agents
GB0514739D0 (en) Therapeutic agents
GB0525124D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)